TPG is ending its eleven-year investment in medical diagnostics company Immucor through a $2bn sale to trade buyer Werfen. The post Eleven years after buying Immucor, TPG is selling the business in a $2bn deal
Private equity major GTCR has agreed a majority investment in medical device contract manufacturing organization Biocoat. The post GTCR buys into medical device contract manufacturing organisation Biocoat first appeared on AltAssets Private Equity News.
A Nordic Capital-led investor group has agreed the £2.25bn sale of medical diagnostics business The Binding Site Group to Thermo Fisher Scientific. The post After more than a decade of ownership, Nordic Capital agrees £2.25bn
Global private equity major Permira has completed the joint acquisition and combination of Kedrion and BPL, creating a major player for medicinal products derived from human blood plasma. The post Permira creates major blood plasma
Hg is welcoming fellow private equity house TA Associates as a new investor in radiology imaging software provider Intelerad, after the firm doubled the size of the business since its buyout two years ago. The
UK mid-market buyout house Graphite Capital has exited scientific animation producer Random42 in a trade deal to The Lockwood Group. The post Graphite Capital exits scientific animation producer Random42 after five years first appeared on AltAssets Private
Biopharma, medical tech and life sciences-focused 5AM Ventures has raised $750m across a new pair of funds targeting startups across the early and late-stage of investment. The post 5AM Ventures ups fundraising ante with $750m
UK-based investment firm Maven Equity has exited Westfield Medical Group to Sterimed Group in a trade deal sealing 2.2x returns. The post Maven Equity seals 2.2x returns from Westfield Medical exit after international expansion first
Veritas Capital has scored a hefty return selling healthcare software developer athenahealth to buyout pair Bain Capital and Hellman & Friedman in a $17bn deal. The post Big return for Veritas Capital as firm agrees
Specialist private equity house WindRose Health Investors has bought into StateServ Medical, a provider of durable medical equipment benefit management solutions for the post-acute care market in the US. The post WindRose Health Investors buys
Mid-market buyout house HGGC has teamed up with Snapdragon Capital Partners for a $240m investment in integrative medicine specialist Fullscript. The post HGGC, Snapdragon Capital team up for $240m Fullscript investment first appeared on AltAssets
Global buyout giant Blackstone has agreed to acquire Australian clinical trials provider Nucleus Network. The post Blackstone to acquire Australian clinical trials provider Nucleus Network eyeing increasing demand from offshore biotech companies first appeared on
Caisse de dépôt et placement du Québec has bought a "significant" minority stake in Grupo Diagnóstico Aries, one of the fastest growing medical diagnostic services groups in Mexico. The post Pension investment major CDPQ buys
Veteran buyout house Kohlberg & Company has bought into Ob Hospitalist Group from fellow PE house Gryphon Investors. The post Kohlberg buys Ob Hospitalist Group from Gryphon Investors first appeared on AltAssets Private Equity News.
Audax Private Equity has bought a majority stake in healthcare-focused mounts, clamps and stands specialist GCX. The post Audax takes stake in medical mount, clamps and stands specialist GCX first appeared on AltAssets Private Equity
The already intensely heated pharmaceutical and medical investment market has grown even more competitive over the past year thanks to rising interest amid the Covid-19 pandemic. Consolidation within the market has also seen the bar
Private equity major GTCR has bought and merged a pair of medical products businesses to create new company Corza Medical.
California-based private equity house HCAP Partners has backed 83bar, which helps to find and retain qualified individuals for clinical trials and commercial clients.
European life science investor LSP has launched a dedicated fund targeting the fight against neurodegenerative diseases. The LSP Dementia Fund will be managed by Professor Philip Scheltens, a world-renowned dementia scientist and thought leader, the firm
Private equity major TA Associates has sealed a growth investment in self-funded medical benefit programme The Benecon Group.
